[HTML][HTML] Exposure of human glioblastoma cells to thimerosal inhibits the thioredoxin system and decreases tumor growth-related factors

I Bramatti, M Aschner, V Branco, C Carvalho - Toxicology and Applied …, 2024 - Elsevier
Glioblastoma multiforme (GBM) is the most common, aggressive, and fatal primary
malignant brain tumor in adults. The therapeutic efficacy of temozolomide (TMZ) is limited …

[HTML][HTML] SUMOylation of RALY promotes vasculogenic mimicry in glioma cells via the FOXD1/DKK1 pathway

S Cao, D Wang, P Wang, Y Liu, W Dong… - Cell Biology and …, 2023 - Springer
Human malignant gliomas are the most common and aggressive primary malignant tumors
of the human central nervous system. Vasculogenic mimicry (VM), which refers to the …

[HTML][HTML] Molecular Targeting of the BRAF Proto-Oncogene/Mitogen-Activated Protein Kinase (MAPK) Pathway across Cancers

KS Shan, TU Rehman, S Ivanov, G Domingo… - International Journal of …, 2024 - mdpi.com
The mitogen-activated protein kinase (MAPK) pathway is essential for cellular proliferation,
growth, and survival. Constitutive activation of this pathway by BRAF mutations can cause …

[HTML][HTML] A simple 3D cell culture method for studying the interactions between human Mesenchymal stromal/stem cells and patients derived Glioblastoma

L Oliver, A Álvarez-Arenas, C Salaud… - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma (GBM) remain an incurable disease despite important efforts
to find efficient treatments. GBM are heterogeneous, complex, and plastic tumors and as …

Hypoxia-inducible PRMT2 addiction in glioblastomas

F Dong, X Sun, J Su, Q Li, Y He, W Li, B Wang… - Cellular …, 2024 - Elsevier
Hypoxia-inducible transcription factors (HIFs) are key transcription factors for cellular
response to low oxygen levels. However, the specific mediators responsible for activating …

[HTML][HTML] Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma

L Dai, P Zhou, L Lyu, S Jiang - BMC cancer, 2023 - Springer
Glioblastoma multiforme (GBM) is recognized as the prevailing malignant and aggressive
primary brain tumor, characterized by an exceedingly unfavorable prognosis. Cuproptosis, a …

Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors

S Hussain, M Mursal, G Verma, SM Hasan… - European Journal of …, 2024 - Elsevier
Protein kinases play pivotal roles in various biological functions, influencing cell
differentiation, promoting survival, and regulating the cell cycle. The disruption of protein …

[HTML][HTML] Non-apoptotic programmed cell death in thyroid diseases

F Ji, X Qiu - Pharmaceuticals, 2022 - mdpi.com
Thyroid disorders are among the most common endocrinological conditions. As the
prevalence of thyroid diseases increases annually, the exploration of thyroid disease …

Research progress on ferroptosis in gliomas

Y Bo, L Mu, Z Yang, W Li, M Jin - Oncology Letters, 2024 - spandidos-publications.com
Glioma is the most prevalent type of brain tumor characterized by a poor 5‑year survival rate
and a high mortality rate. Malignant gliomas are commonly treated by surgery …

Exosome-transmitted ANGPTL1 suppresses angiogenesis in glioblastoma by inhibiting the VEGFA/VEGFR2/Akt/eNOS pathway

D Wang, H Li, T Zeng, Q Chen, W Huang… - Journal of …, 2024 - Elsevier
Objective Glioblastoma (GBM) is a highly vascularized malignancy that relies on new vessel
generation, and thus targeting angiogenesis has been a promising anti-GBM approach …